These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
461 related items for PubMed ID: 27299917
1. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T. Xu XQ, Hu H, Liu H, Wu JF, Cao P, Shi HB, Wu FY. J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917 [Abstract] [Full Text] [Related]
2. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging. Hu H, Xu XQ, Liu H, Hong XN, Shi HB, Wu FY. Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215 [Abstract] [Full Text] [Related]
3. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability. Qian W, Xu XQ, Hu H, Su GY, Wu JF, Shi HB, Wu FY. J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524 [Abstract] [Full Text] [Related]
5. Orbital lymphoproliferative disorders (OLPDs): value of MR imaging for differentiating orbital lymphoma from benign OPLDs. Haradome K, Haradome H, Usui Y, Ueda S, Kwee TC, Saito K, Tokuuye K, Matsubayashi J, Nagao T, Goto H. AJNR Am J Neuroradiol; 2014 Oct; 35(10):1976-82. PubMed ID: 24874530 [Abstract] [Full Text] [Related]
6. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses. Xu XQ, Qian W, Ma G, Hu H, Su GY, Liu H, Shi HB, Wu FY. Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096 [Abstract] [Full Text] [Related]
7. Differentiation of orbital lymphoma and idiopathic orbital inflammatory pseudotumor: combined diagnostic value of conventional MRI and histogram analysis of ADC maps. Ren J, Yuan Y, Wu Y, Tao X. BMC Med Imaging; 2018 May 02; 18(1):6. PubMed ID: 29716527 [Abstract] [Full Text] [Related]
10. Orbital Indeterminate Lesions in Adults: Combined Magnetic Resonance Morphometry and Histogram Analysis of Apparent Diffusion Coefficient Maps for Predicting Malignancy. Xu XQ, Hu H, Su GY, Zhang L, Liu H, Hong XN, Shi HB, Wu FY. Acad Radiol; 2016 Feb 02; 23(2):200-8. PubMed ID: 26625705 [Abstract] [Full Text] [Related]
12. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI. Kuang F, Yan Z, Li H, Feng H. J Magn Reson Imaging; 2015 Oct 02; 42(4):1094-9. PubMed ID: 25824638 [Abstract] [Full Text] [Related]
15. Evaluation of extracapsular extension in prostate cancer using qualitative and quantitative multiparametric MRI. Kim W, Kim CK, Park JJ, Kim M, Kim JH. J Magn Reson Imaging; 2017 Jun 02; 45(6):1760-1770. PubMed ID: 27749009 [Abstract] [Full Text] [Related]
16. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging. Wang F, Sha Y, Zhao M, Wan H, Zhang F, Cheng Y, Tang W. J Comput Assist Tomogr; 2017 Jun 02; 41(2):199-205. PubMed ID: 27560026 [Abstract] [Full Text] [Related]
18. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method. Xu XQ, Hu H, Su GY, Liu H, Shi HB, Wu FY. Korean J Radiol; 2016 Jun 02; 17(5):650-6. PubMed ID: 27587953 [Abstract] [Full Text] [Related]
19. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy. Zhang M, Horvat JV, Bernard-Davila B, Marino MA, Leithner D, Ochoa-Albiztegui RE, Helbich TH, Morris EA, Thakur S, Pinker K. J Magn Reson Imaging; 2019 Mar 02; 49(3):864-874. PubMed ID: 30375702 [Abstract] [Full Text] [Related]